HFM
ORMP icon

Harvest Fund Management’s Oramed Pharmaceuticals ORMP Stock Holding History

Harvest Fund Management’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-344
Closed -$4K – 776
2021
Q4 		$4K Buy
+344
New +$7.19K ﹤0.01% 734

Other funds holding ORMP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return

Harvest Fund Management's ORMP Position: Q1 2022 in Review

Harvest Fund Management sold out of Oramed Pharmaceuticals (ORMP) in Q1 2022, closing a stake of 344 shares — an estimated $4K sold.

Harvest Fund Management first reported a position in ORMP in Q4 2021 and held it in 1 quarter. The position peaked at $4K in Q4 2021. 103 funds tracked by Wall St. Rank hold ORMP as of Q1 2022.

  • Harvest Fund Management reported no remaining Oramed Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Harvest Fund Management sold 344 Oramed Pharmaceuticals shares in Q1 2022, an estimated $4K.
  • Harvest Fund Management first reported a position in Oramed Pharmaceuticals in Q4 2021 and held it in 1 quarter.
  • Harvest Fund Management's Oramed Pharmaceuticals position peaked at $4K in Q4 2021.
  • 103 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q1 2022.

Based on Harvest Fund Management's 13F filing for Q1 2022, filed 12 May 2022.